Sedation dentistry trends in the United States remains a growing but poorly standardised segment of dental care.
The strongest national signals over 2021–2026 are: persistent demand driven by dental fear and delayed care; recovery from COVID-era disruption by 2022; continued dominance of nitrous oxide for minimal sedation and oral/IV sedation for higher-anxiety or longer procedures; and a marked regulatory turn towards tighter documentation, training, emergency preparedness and oversight.
Nationally, high-quality utilisation data are fragmented: the best broad access proxy is the ADA Health Policy Institute’s finding that dental visits rose from 43% of the U.S. population in 2021 to 45% in 2022, largely back to pre-COVID levels, while CDC data show sharp 2019–2020 declines in adult and child dental visits during the pandemic.
For sedation specifically, AAOMS/FAIR Health private-claims work indicates 24.2 million insured individuals received office-based dental anaesthesia services in 2018–2021, including 8.9 million moderate or deep sedation/general anaesthesia cases, with oral and maxillofacial surgeons performing 78% of those higher-acuity cases.
Safety remains the central policy issue. There is still no comprehensive national mandatory dental anaesthesia incident registry, so the literature relies on closed malpractice claims, specialty registries and state enforcement.
Recent reviews emphasise substantial variation across state rules, inconsistent adverse-event reporting, and the need for more uniform emergency-readiness standards.
In April 2026, the ADA released its first major sedation and anaesthesia guideline overhaul in nearly a decade, adding updated ASA/fasting expectations, BMI and weight-based dosing documentation, oxygen expectations, and stronger protocol and drill requirements.
For Anna in Texas, public data are sparse. The city appears to have a small in-city sedation footprint, with at least two practices publicly advertising sedation services: Anna Dental (nitrous, oral, IV) and Anna Kids Dentistry (laughing gas, oral, IV).
No Anna-specific public utilisation, reimbursement or incident series were found; the best proxies are Collin County and nearby Dallas–area specialist and hospital markets.
Texas is comparatively structured: dentists need permit-specific privileges, recurrent jurisprudence testing, sedation CE, life-support credentials, inspections for higher-level permit holders, and separate paediatric/high-risk endorsements for level 2–4 sedation.
Learn more about sedation dentistry trends across the U.S. and in Anna, TX.
Methodology and evidence base
This report covers 2021–2026, with forecasts to 2031–2036. I prioritised official and primary sources: American Dental Association/HPI, Centers for Disease Control and Prevention/NCHS, NIDCR, AHRQ/MEPS, Texas State Board of Dental Examiners, Texas HHSC/OIG, U.S. Census, peer-reviewed papers, and local clinic websites.
For Anna, where city-level public data were unavailable, I used Collin County and nearby north-Dallas-metro provider and payment proxies, explicitly marked as proxies.
Market-size estimates are the least “official” part of the brief and rely on secondary market research because no U.S. government series directly measures the sedation-dentistry market.
National U.S. trends
Demand fundamentals remain strong. NIDCR’s Oral Health in America reports that nearly 1 in 5 U.S. adults experience moderate to high dental fear/anxiety, and a 2025 JADA-reported survey found dental fear to be even more pervasive when measured broadly.
That matters because sedation is fundamentally a response to fear, complexity, special needs, and treatment consolidation.
Demographically, child and older-adult populations are especially relevant: children often need behavioural management or GA for extensive disease, while older adults with comorbidities need more careful risk stratification.
COVID-19 depressed overall dental utilisation first, then reshaped sedation demand. CDC/NCHS showed adult dental visits falling from 65.5% to 62.7% between 2019 and 2020, and children’s annual examinations/cleanings dropping from 83.8% to 80.9%, with the biggest fall among ages 1–4.
ADA HPI polling in early 2022 still found patient volume at 84% of current staffed capacity, with staffing shortages cutting capacity by about 11%. By 2022, however, ADA HPI reported overall dental attendance back near pre-pandemic levels.
For sedation, the practical legacy was backlog: more deferred treatment, more multi-procedure appointments, and continued paediatric pressure for hospital/GA access where disease worsened during delays.
The modality mix has remained stable. Nitrous oxide is still the commonest minimal-sedation entry point because it is fast-on/fast-off and simple to recover from.
Oral sedation remains common for moderate anxiety and general-practice settings. IV sedation is used disproportionately for longer, more invasive or anxiety-heavy care.
General anaesthesia remains concentrated in oral surgery, paediatrics, special-needs care and hospital/ASC settings.
AAOMS’ FAIR Health-based white paper suggests the best available scale estimate: moderate and deep/general anaesthesia cases totalled 8.89 million in 2018–2021, and oral and maxillofacial surgeons delivered 78% of that higher-acuity workload; in children aged 8–12 requiring deep sedation/GA, OMSs delivered 80% of procedures.
A 2025 multi-state permit study also found permit growth in Texas: minimal-sedation permits rose from 33.6% to 41.6% of licensed dentists between 2015 and 2023, and moderate-sedation permits from 15.3% to 21.2%, implying expanding capacity heading into 2021–2026.
Safety evidence is improving, but still incomplete.
A 2024 review concluded that dental office anaesthesia remains hampered by weak systemic data collection, making insurance claims and closed-claims files some of the few usable morbidity/mortality sources.
A 2025 review of state rules found major interstate inconsistency in definitions, monitoring, reporting and training requirements.
In paediatric claims, older but still influential malpractice work continues to shape policy: local anaesthetic overdose appeared in 41% of reviewed claims, and monitoring was often poorly documented.
More recent outpatient paediatric deep-sedation studies and reviews generally describe favourable safety when appropriate screening, rescue capability and monitoring are in place, but they reinforce that respiratory compromise, desaturation, dosing error and recovery monitoring remain the key hazards.
Training and certification tightened further in 2025–2026.
The ADA’s revised 2026 sedation and teaching guidelines are the biggest national change in the period: they update ASA physical-status and fasting recommendations, require more precise weight-based and BMI documentation, recommend supplemental oxygen for moderate sedation through GA, and emphasise emergency preparedness and regular drills.
These guidelines are not law by themselves, but they are intended to inform state boards and CODA-aligned educational standards. In parallel, the Texas board continued formal review of Chapter 110 in 2025, while its advisory work increasingly focused on pre-operative checklist detail and local-anaesthetic dose calculation after incident reviews.
Reimbursement remains a constraint. Coverage is usually strongest when sedation is medically or dentally necessary for complex surgery, disability, very young children, or hospital-based treatment.
Medicaid must provide children’s dental benefits under EPSDT, but adult dental coverage remains variable by state. Medicare still does not cover routine dental care or anxiety-only sedation, although it may cover dental services that are inextricably linked to a covered medical service.
Commercial payers often exclude GA/IV sedation for anxiety control alone; Cigna plan documents explicitly say GA/IV sedation for anxiety control is not covered unless medically or dentally necessary and tied to covered complex oral surgery.
Coding clarity improved in CDT 2026, which added and revised anaesthesia codes to better reflect contemporary reporting.
Market data are imprecise, but directionally clear. Secondary analysts cluster the global dental-anaesthesia market around roughly $2.1–$2.4 billion in 2025, with CAGR estimates near 4%–6% through 2032–2035; one 2025 estimate places U.S. market size near $0.64 billion, while North America is generally the largest regional market.
These figures should be treated cautiously, but they are consistent with the underlying drivers: more implants/oral surgery, a growing older population, more digitally enabled practice workflows, and rising consumer expectation for pain-controlled care.
Anna, Texas and Collin County snapshot
Anna is a fast-growing, relatively affluent north-Collin community.
U.S. Census QuickFacts puts the city’s population at 24,330 in 2024 and 31,986 in 2025, with median household income of $105,593 and mean travel-to-work time of 30.7 minutes; Collin County grew from a 2020 base of about 1.07 million people to 1.30 million in 2025.
That growth supports demand for family dentistry, paediatric services and treatment-completion models that reward sedation availability.
Publicly documented in-city sedation supply appears limited but real. Anna Dental advertises nitrous oxide, oral sedation and IV sedation.
Anna Kids Dentistry advertises laughing gas, oral sedation and IV sedation for paediatric patients.
Anna Smiles Dental was identified as a general family practice, but no sedation offering was clearly stated on the reviewed pages, so I classify its sedation availability as unspecified publicly.
For higher-complexity oral surgery or likely GA pathways, residents appear to rely on nearby Melissa, McKinney, Plano, Frisco or Dallas specialists and hospital settings.
Texas regulation shapes local delivery more than any Anna-specific ordinance.
The Texas board requires permit-specific privileges for nitrous oxide, level 1 minimal sedation, level 2 moderate enteral sedation, level 3 moderate parenteral sedation and level 4 deep sedation/general anaesthesia.
Permit holders must renew with sedation-specific CE, maintain BLS and, for higher levels, ACLS/PALS as applicable, pass Chapter 110 jurisprudence every five years, and obtain separate authorisation for paediatric/high-risk level 2–4 sedation.
TSBDE also treats its searchable licence system as a primary source for current permit verification and public actions.
Local access appears adequate for minimal-to-moderate sedation but thinner for GA and medically complex cases.
That is typical of smaller fast-growing suburbs: general practices can offer nitrous and some oral/IV sedation, but paediatric GA, special-needs anaesthesia and surgeon-led deep sedation cluster in larger centres.
Anna Dental’s own site says it serves Melissa, McKinney and Sherman as well as Anna, which indirectly signals a regional catchment rather than purely neighbourhood supply.
Anna-specific incident reporting is effectively unspecified publicly. No city-attributed Anna sedation incident series or public board summary was located.
The strongest Texas-specific safety signal comes instead from HHSC OIG, which highlighted common dental sedation errors such as failure to document vital signs, recordkeeping flaws and monitoring defects; Texas board public actions also show anaesthesia-record omissions as an enforcement issue.
Anna-specific referral patterns are likewise unspecified in formal data, but nearby paediatric and oral-surgery websites strongly suggest the usual pathway: routine fear management locally, then referral outward for hospital/general anaesthesia or specialist surgical sedation.
Comparison tables
The table below compares the main modalities using the highest-confidence public evidence available.
Forecast, implications and research gaps
My base-case forecast for 2027–2036 is continued mid-single-digit growth in sedation-related dental services and products, with IV sedation growing fastest in private practice and surgeon-led settings, oral sedation remaining stable, nitrous oxide staying high-volume but not necessarily high-growth, and GA continuing to expand mainly in paediatric, special-needs and medically necessary surgical pathways.
The assumptions are straightforward: dental fear remains common; Texas permit prevalence has been rising; older adults and implant/oral-surgery volumes are growing; and coding changes plus teledentistry support smoother pre-op triage and documentation.
Offsetting that, reimbursement will stay patchy, workforce shortages will constrain capacity, and stricter rules will raise compliance costs.
For Anna, the most likely local outcome is not a stand-alone “sedation boom”, but gradual maturation from a small in-city sedation base towards a clearer hub-and-spoke model: nitrous/oral/selected IV cases handled in town; specialist IV/deep sedation and most GA referred to McKinney/Plano/Frisco/Dallas; and more administrative use of teledentistry for consultation, records review and prior authorisation. Texas’ March 2025 teledentistry implementation is relevant here, even if procedural sedation itself still requires in-person care.
The main policy implication is that access and safety are now inseparable.
Nationally, uniform adverse-event reporting and office-anaesthesia transparency remain the biggest missing pieces. In Texas, the more immediate implication is operational: practices offering sedation should expect continuing pressure for stronger checklists, dosing documentation, drills and permit verification.
In Anna, the highest-value public-health lever is referral coordination, especially for very young children, special-needs patients and medically complex adults.
Research gaps are material. Anna-specific data on sedation utilisation, prices paid, payer mix, referral leakage, waits, and incidents are not publicly available.
There is no city-level TSBDE sedation dashboard, and clinic websites are an imperfect proxy because marketing pages do not prove active permit status on a given day.
Nationally, the field still lacks a mandatory, standardised adverse-event registry spanning general dentists, paediatric dentists, OMS, mobile anaesthesia and hospital-based providers.
Those gaps make Texas board records, payer policy documents and practice-level transparency disproportionately important for future research.
References
National Trends in Dental Care Use, Dental Insurance Coverage, and Cost Barriers
Office-based Anesthesia Provided by the Oral and Maxillofacial Surgeon
Trends in Dental Sedation Permits in Select U.S. States, 2015–2023
Oral Health in America – April 2022 Bulletin
Dental Care Utilization Among Adults Aged 18−64: United States, 2019 and 2020
The Path to Safety in Dental Anesthesia
ADA releases updated sedation and anesthesia guidelines
North America Dental Anesthesia Market Share and Trends Analysis
